Home » Newsletters » BioWorld Asia

BioWorld Asia

June 21, 2000

View Archived Issues

Qiagen Acquiring Operon In Stock Deal Valued At $110M

EU Ministers Take Steps To Promote European Research

French Oppose Commission Directive On Biotech Patents

NsGene, Biogen Collaborate In Neublastin Deal Worth $20M

Kirkman Seeks Greater Role For BIA As He Assumes Top Position

Recap Of Deals, Financings Now Available From BioWorld

GPC Biotech, Karo Collaborate To Identify Novel Antibiotics

Commissioner Says Industry Brought GMO Flap On Itself

OECD Report To G8 Calls For Harmonization Of Regulations

Lorantis Completing First Round To Fund Program Around Notch

QBI Plans IPO As Biotech In Israel Gets Venture Boost

Other News To Note

Bioniche Identifies New Class Of Molecules Against Cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...